Going back to the 2015 presidential campaign, both sides of the political aisle made several promises about targeting the price of prescription drugs. On May 11, 2018 the Trump Administration released the ‘American Patients…
On May 11, the Trump Administration released the ‘American Patients First’ Blueprint[1] to tackle the rising cost of drugs, with major impacts to pharmaceutical companies and pharmacy benefit managers. Department of Health and Human…
On May 9th, the Trump Administration released its semiannual Spring 2018 Unified Agenda of Regulatory and Deregulatory Actions (Agenda), which offered a preview into various agencies’ plan of actions in progressing towards more…
Introduction On December 7, 2016, the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services (HHS) published a final rule (Final Rule) that provides amendments to the Anti-Kickback…
Background In February 2018, the United States Attorney’s Office for the Southern District of Florida – historically one of the most active districts prosecuting healthcare fraud – intervened in a qui tam suit filed…
Ride-hailing companies, like Uber and Lyft, have partnered with many hospitals and providers to offer ridesharing services to patients seeking non-emergency medical transportation (NEMT) to receive various care services. Largely, this strategy makes sense: According…
Earlier this year, the Department of Justice (DOJ) issued two policy memos that will directly affect its civil enforcement priorities, particularly with regard to healthcare and life sciences companies. Companies now have a better chance…
The U.S. Court of Appeals for the Third Circuit has cleared Medco Health Solutions of violating the Anti-Kickback Statute, finding in a precedential ruling that a whistleblower failed to show a connection between alleged kickbacks…
Welcome to our new website! Take a moment to explore and be sure to check back regularly for more information about our services. If you have any questions please get in touch with us and…